Varol, U. Et Al. 2014. Markers to predict the efficacy of bevacizumab in the treatment of metastatic colorectal cancer. TUMORI J , vol.100, no.4 , 370-376.

Varol, U., Yildiz, İ., Salman, T., KARABULUT, B., & Uslu, R., (2014). Markers to predict the efficacy of bevacizumab in the treatment of metastatic colorectal cancer. TUMORI J , vol.100, no.4, 370-376.

Varol, Umut Et Al. "Markers to predict the efficacy of bevacizumab in the treatment of metastatic colorectal cancer," TUMORI J , vol.100, no.4, 370-376, 2014

Varol, Umut Et Al. "Markers to predict the efficacy of bevacizumab in the treatment of metastatic colorectal cancer." TUMORI J , vol.100, no.4, pp.370-376, 2014

Varol, U. Et Al. (2014) . "Markers to predict the efficacy of bevacizumab in the treatment of metastatic colorectal cancer." TUMORI J , vol.100, no.4, pp.370-376.

@article{article, author={Umut Varol Et Al. }, title={Markers to predict the efficacy of bevacizumab in the treatment of metastatic colorectal cancer}, journal={TUMORI J}, year=2014, pages={370-376} }